These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15906848)

  • 1. Spotted dermopathy in a diabetic patient due to insulin allergy.
    Maheshwari M; Goyal D; Desouza P; Goyal RK
    J Assoc Physicians India; 2004 Nov; 52():926-7. PubMed ID: 15906848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
    Mollar-Puchades MA; Villanueva IL
    Diabetes Res Clin Pract; 2009 Jan; 83(1):e21-2. PubMed ID: 19070911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
    Bazzano LA; Lee LJ; Shi L; Reynolds K; Jackson JA; Fonseca V
    Diabet Med; 2008 Aug; 25(8):924-32. PubMed ID: 18959605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Documented advantages of Lantus in comparison with NPH].
    Birgersson MO
    Lakartidningen; 2004 Oct; 101(42):3270, 3273; author reply 3273. PubMed ID: 15544137
    [No Abstract]   [Full Text] [Related]  

  • 5. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy in NIDDM.
    Raskin P
    N Engl J Med; 1992 Nov; 327(20):1453-4. PubMed ID: 1406863
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of an intermediate action insulin in diabetics non-respondents to oral treatment].
    Díaz C J; Moneada V S; Orriols W M; Durruty A P
    Rev Med Chil; 2007 Oct; 135(10):1358-60. PubMed ID: 18180847
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin detemir under steady-state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes.
    Bott S; Tusek C; Jacobsen LV; Endahl L; Draeger E; Kapitza C; Heise T
    Diabet Med; 2006 May; 23(5):522-8. PubMed ID: 16681561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immediate protamine sulphate allergy in an insulin-treated diabetic patient].
    Petäys T; Kiistala R; Mäkinen-Kiljunen S
    Duodecim; 1999; 115(5):517-20. PubMed ID: 11830901
    [No Abstract]   [Full Text] [Related]  

  • 10. Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.
    Dailey G; Strange P
    Am J Manag Care; 2008 Jan; 14(1):25-30. PubMed ID: 18197742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Local complications in the skin related to the administration of insulin].
    Camata DG
    Rev Lat Am Enfermagem; 2003; 11(1):119-22. PubMed ID: 12733253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe insulin allergy after percutaneous transluminal coronary angioplasty.
    Wang C; Ding ZY; Shu SQ; Liu Y; Chen YC; Ran XW; An ZM; Tian HM; Tong NW; Li XJ; Yu YR
    Clin Ther; 2009 Mar; 31(3):569-74. PubMed ID: 19393846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C; Hernández Herrero C; Rivas Fernández M
    Diabet Med; 2008 Aug; 25(8):916-23. PubMed ID: 18959604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flocculation of NPH insulin].
    Playán J; Acha J; Navarro H; Sanz A; Guallar AM; Albero R
    Rev Clin Esp; 1994 Jan; 194(1):20-2. PubMed ID: 8153409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in type 2 diabetic patients on basal-prandial insulin therapy.
    Yokoyama H; Tada J; Kamikawa F; Kanno S; Yokota Y; Kuramitsu M
    Diabetes Res Clin Pract; 2006 Jul; 73(1):35-40. PubMed ID: 16513202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial examining combinations of repaglinide, metformin and NPH insulin.
    Davies MJ; Thaware PK; Tringham JR; Howe J; Jarvis J; Johnston V; Kitchener DL; Skinner TC; McNally PG; Lawrence IG
    Diabet Med; 2007 Jul; 24(7):714-9. PubMed ID: 17403126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early retinopathy progression in four randomized trials comparing insulin glargine and NPH [corrected] insulin.
    Davis MD; Beck RW; Home PD; Sandow J; Ferris FL
    Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):240-3. PubMed ID: 17479440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoatrophy at insulin injection site.
    Velayutham P; Shriraam M; Bhadada S; Bhansali A
    J Assoc Physicians India; 2008 May; 56():335. PubMed ID: 18700641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.